CytoDyn Inc. — Form D

CytoDyn Inc. of VANCOUVER, WA, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-02. The offering totals $5.0M, of which $3.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (102)

Showing 25 of 102 people.

NameRoleLocation
Carl C. DockeryRelated PersonVancouver, WA
Gregory A. GouldRelated PersonVancouver, WA
Scott A. KellyRelated PersonVancouver, WA
Michael A. KlumpRelated PersonAtlanta, GA
Michael D. MulhollandRelated PersonVancouver, WA
Jordan G. NaydenovRelated PersonVancouver, WA
Richard G. PestellRelated PersonVancouver, WA
Nader Z. PourhassanRelated PersonVancouver, WA
David F. WelchRelated PersonVancouver, WA
Michael A KlumpDirectorAtlanta, GA
Richard G PestellDirectorWynnewood, PA
Richard G PestellExecutive OfficerWynnewood, PA
Ryan G DunlapDirectorVancouver, WA
Arvin Cyrus ArmanExecutive OfficerVancouver, WA
Karen J BrunkeDirectorVancouver, WA
Antonio Durkee MigliareseExecutive OfficerVancouver, WA
Lishomwa C NdhlovuDirectorVancouver, WA
Tanya Durkee UrbachDirectorVancouver, WA
Nitya G RayExecutive OfficerVancouver, WA
Antonio G MigliareseExecutive OfficerVancouver, WA
Christopher G RecknorExecutive OfficerVancouver, WA
Harish Z SeethamrajuDirectorVancouver, WA
Scott A Kelly, M.D.DirectorVancouver, WA
Scott A Kelly, M.D.Executive OfficerVancouver, WA
Nitya G Ray, Ph.D.Executive OfficerVancouver, WA

Other filings by this issuer (31)

Showing 15 of 31 filings.

FiledFormOfferingSold
2026-05-11D$18.6M$18.6M
2022-09-19D/A$21.8M$21.8M
2022-04-25D/A$1.9M
2022-04-22D$1.9M
2021-12-03D$53.6M$11.4M
2021-09-16D$25.2M$2.9M
2020-12-16D$1.2M
2020-12-16D$1.0M$1.0M
2020-04-07D/A$11.4M$7.6M
2020-03-30D$1.2M$882K
2020-02-14D$7.6M$7.6M
2019-11-12D/A$20.0M$7.8M
2018-09-10D$25.0M$13.2M
2018-02-28D/A$17.6M$17.6M
2017-11-16D$15.0M$1.2M

More